Skip to Content
NorthShore is part of Endeavor Health Learn more ›

NorthShore Research Institute

Home » Research Institute » Investigators » Sean P. David, MD, SM, D. Phil

Sean P. David , MD, SM, DPhil

Program Director for Translational Science, Outcomes Research
Clinical Professor and Vice Chair for Research, Department of Family Medicine,
University of Chicago, Pritzker School of Medicine

Contact Information

 401.265.2275
 224.364.7370
mailto:sdavid@northshore.org

Education

Colleges and Universities Attended:

  • 1986 – 1990: B.S., Zoology, University of Washington College of Arts and Sciences
  • 1991 – 1995: M.D., Medicine, University of Washington School of Medicine
  • 1998 – 1999: S.M., Health & Social Behavior, Harvard T.H. Chan School of Public Health
  • 2002 – 2006: D.Phil., Pharmacology, Green College, University of Oxford

Residency Training:

  • 1995 – 1998: Residency (Chief Resident), Family Medicine, New Hampshire Dartmouth Family Medicine Residency Program, Dartmouth-Hitchcock Medical Center

Leadership Fellowships:

  • 2011 – 2013: James C. Puffer, M.D./American Board of Family Medicine/National Academy of Medicine Anniversary Fellowship, National Academies of Science, Engineering and Medicine
  • 2020 – 2021: Leadership Education for Academic Development and Success (LEADS) Fellowship, Association of Departments of Family Medicine
  • 2020 – 2021: Program for Leadership Development, Harvard Business School

Research Fellowships:

  • 2000 – 2003: Koop Fellow (Cancer Prevention), C. Everett Koop Institute at Dartmouth
  • 2000 – 2002: Visiting Fellow, Cancer Research UK General Practice Research Group, University of Oxford
  • 2002 – 2006: Generalist Physician Faculty Scholars Program, Robert Wood Johnson Foundation

Board Certification

  • 1998 – 2005: Board certification, American Board of Family Medicine; Recertification in 2005 and 2015

Research and Academic Interests

  • Smoking cessation and tobacco control
  • Genetics & omics, pharmacogenetics, and personalized medicine
  • Health equity
  • Clinical implementation science
  • Clinical trials
  • Meta-research
  • Open science
  • Health policy

Career Summary

Sean P. David, M.D., S.M., D.Phil. is Clinical Professor of Family Medicine and Vice Chair for Research at the Pritzker School of Medicine, University of Chicago and he is Program Director for Translational Science in Outcomes Research at the NorthShore University HealthSystem. He is engaged in numerous research and research leadership activities at NorthShore and the University of Chicago including the NorthShore Center for Personalized Medicine (PMed), the University of Chicago/Rush University CTSA (Institute for Translational Medicine), and the University of Chicago Department of Family Medicine Steering Committee on Academic Integration and directs the Primary Care & Population Health Investigators Group (PCPH). He is presently a LEADS (Leadership Education for Academic Development and Success) Fellow with the Association for Departments of Family Medicine and is concurrently a student with the Harvard Business School Program for Leadership Development (both fellowships run 2020-2021).

Dr. David is an accomplished researcher in tobacco control, smoking cessation treatment, pharmacogenomics, genomic discovery science, and implementation of precision medicine in primary care. He recently came to the University of Chicago from Stanford University (2009-2019), where he was Associate Professor of Medicine in the Division of Primary Care and Population Health, was a member of the Stanford Cancer Institute, and led multiple NIH-funded clinical trials, studied precision health equity implementation projects, and served as a co-investigator with the Women’s Health Initiative, the Meta-Research Innovation Center at Stanford (METRICS), and NeuroChoice with the Stanford Neuroscience Institute. His research has identified genomic predictors of tobacco use and lung cancer, smoking cessation pharmacogenomics, and genomic biomarkers in multiethnic populations. He has served as a NAM Consensus Committee on the Evidence Base for Genetic Testing and was a co-author of the NAM Consensus Report, “The Evidence Base for Genetic Testing” in 2017; was Editor of the text book “Genomic and Precision Medicine, Primary Care” (Elsevier Press, 2017); was a member of the National Comprehensive Cancer Network (NCCN) Smoking Cessation Guideline Panel. He has also served on numerous national leadership committees including the ABFM Young Leaders Advisory Group, as Co-Director of the Society for Research on Nicotine and Tobacco (SRNT) Genetics and Omics Network and has served as Chair and Co-Chair of the Program Committee for SRNT Annual Meetings, as well as numerous NIH review committees and as a reviewer for the 2020 Surgeon General’s Report on Smoking Cessation.

He received his medical degree from the University of Washington School of Medicine, his Master of Science in Health and Social Behavior from the Harvard T.H. Chan School of Public Health, and his doctorate (DPhil) from the University of Oxford, where he studied pharmacogenomics and neuroscience. He completed his family medicine residency at the New Hampshire-Dartmouth Family Medicine Residency Program. He subsequently completed the James C. Puffer, MD/American Board of Family Medicine (ABFM)/National Academy of Medicine (NAM) Anniversary Fellowship in 2013. Prior to his ten years at Stanford, he was an Assistant Professor and Research Director in the Department of Family Medicine at the Alpert Medical School of Brown University (1999-2009).

Honors and Awards

  • 1997: Glaxo-Wellcome Family Practice Scholar Award, American Academy of Family Physicians
  • 2001: Dean’s Teaching Excellence Award, Warren Alpert Medical School of Brown University
  • 2001: Advanced Research Training Award, American Academy of Family Physicians
  • 2002 Profiles in Competence Award (Lifelong Learning), Warren Alpert Medical School of Brown University
  • 2002: New Investigator Travel Award, Society for Research on Nicotine & Tobacco, National Cancer Institute
  • 2002: Generalist Physician Faculty Scholars Award, Robert Wood Johnson Foundation
  • 2002: Mentored Clinical Scientist Award, National Institute on Drug Abuse
  • 2010: Benjamin Meaker Visiting Professor, Institute of Advanced Studies & Department of Experimental Psychology, University of Bristol
  • 2011: Inaugural James C. Puffer, M.D./American Board of Family Medicine/National Academy of Medicine Anniversary Fellow, National Academy of Medicine
  • 2013: Women’s Health Initiative Poster Award, Women’s Health Initiative and National Health, Lung and Blood Institute
  • 2013: Service Award for Co-Chairing the Program Committee of the SRNT Annual Meeting, Society for Research on Nicotine and Tobacco (SRNT)
  • 2013: US Board of British Medical Journal (BMJ) Fellows, BMJ
  • 2014: Service Award for Chairing the Program Committee of the SRNT Annual Meeting, SRNT
  • 2017: Degree of Fellow, American Academy of Family Physicians (FAAFP)
  • 2018: Presidential Letter of Appreciation for Service to the SRNT
  • 2019: Service Award for Co-Chairing the SRNT Genetics & Omics Network, SRNT
  • 2019/2020: Service Value Awards for Excellent Patient Care on 11/22/2019 and 01/24/2020, NorthShore University HealthSystem
  • 2020: Loyalty Leader Award, NorthShore University HealthSystem

Professional Memberships/Affiliations/Activities

  • 1998 – present: American Academy of Family Physicians
  • 2000 – present: American Medical Association
  • 2002 – present North American Primary Care Research Group
  • 2001 – present: Society for Research on Nicotine and Tobacco (SRNT): 2012 – 2013: Co-Chair, SRNT 19th Annual Meeting; 2013–2014: Chair, SRNT 20th Annual Meeting; 2017 – 2019 Co-Chair, SRNT Genetics & Omics Network; 2019 – 2020: Member, SRNT Purpose and Role Working Group
  • 2010 – present: Young Leaders Advisory Group, American Board of Family Medicine
  • 2013 – 2014: Member, Dialogue on Harm Reduction II, The Schroeder Institute for Tobacco Research and Policy Studies
  • 2013 – 2015: Scientific Advisory Committee, Tobacco-Related Disease Research Program, University of California Office of the President
  • 2015 – 2017: Member, Committee on the Evidence Base for Genetic Testing, National Academy of Medicine
  • 2009 – present: California Academy of Family Physicians
  • 2014—2019: National Comprehensive Cancer Network, Smoking Cessation Guideline Panel (Stanford Cancer Institute representative)

Scholarly Work

A list of my publications can be found at:

https://www.ncbi.nlm.nih.gov/myncbi/1VoErE7ZSsi5d/bibliography/public/

  1. Rosas LG, Nasrallah C, Park VT, Vasquez JJ, Duron Y, Garrick O, Hattin R, Cho M, David SP, Evans J, McClinton-Brown R, Martin C. Perspectives on Precision Health Among Racial/Ethnic Minority Communities and the Physicians That Serve Them. Ethn Dis. 2020;30(Suppl 1):137-148. PubMed PMID: 32269455; PubMed Central PMCID: PMC7138446.
  2. Kessler MD, Loesch DP, Perry JA, Heard-Costa NL, Taliun D, Cade BE, Wang H, Daya M, Ziniti J, Datta S, Celedón JC, Soto-Quiros ME, Avila L, Weiss ST, Barnes K, Redline SS, Vasan RS, Johnson AD, Mathias RA, Hernandez R, Wilson JG, Nickerson DA, Abecasis G, Browning SR, Zöllner S, O'Connell JR, Mitchell BD, O'Connor TD. De novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population. Proc Natl Acad Sci U S A. 2020 Feb 4;117(5):2560-2569. PMID: 31964835; PubMed Central PMCID: PMC7007577.
  3. Kachroo P, Hecker J, Chawes BL, Ahluwalia TS, Cho MH, Qiao D, Kelly RS, Chu SH, Virkud YV, Huang M, Barnes KC, Burchard EG, Eng C, Hu D, Celedón JC, Daya M, Levin AM, Gui H, Williams LK, Forno E, Mak ACY, Avila L, Soto-Quiros ME, Cloutier MM, Acosta-Pérez E, Canino G, Bønnelykke K, Bisgaard H, Raby BA, Lange C, Weiss ST, Lasky-Su JA. Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children With Asthma. Chest. 2019 Dec;156(6):1068-1079. PubMed PMID: 31557467; PubMed Central PMCID: PMC6904857.
  4. Panagiotou OA, Schuit E, Munafò MR, Bennett DA, Bergen AW, David SP. Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?. Nicotine Tob Res. 2019 Aug 19;21(9):1289-1293. PubMed PMID: 30690475; PubMed Central PMCID: PMC6698953.
  5. Brazel DM, Jiang Y, Hughey JM, Turcot V, Zhan X, Gong J, Batini C, Weissenkampen JD, Liu M, Barnes DR, Bertelsen S, Chou YL, Erzurumluoglu AM, Faul JD, Haessler J, Hammerschlag AR, Hsu C, Kapoor M, Lai D, Le N, de Leeuw CA, Loukola A, Mangino M, Melbourne CA, Pistis G, Qaiser B, Rohde R, Shao Y, Stringham H, Wetherill L, Zhao W, Agrawal A, Bierut L, Chen C, Eaton CB, Goate A, Haiman C, Heath A, Iacono WG, Martin NG, Polderman TJ, Reiner A, Rice J, Schlessinger D, Scholte HS, Smith JA, Tardif JC, Tindle HA, van der Leij AR, Boehnke M, Chang-Claude J, Cucca F, David SP, Foroud T, Howson JMM, Kardia SLR, Kooperberg C, Laakso M, Lettre G, Madden P, McGue M, North K, Posthuma D, Spector T, Stram D, Tobin MD, Weir DR, Kaprio J, Abecasis GR, Liu DJ, Vrieze S. Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use. Biol Psychiatry. 2019 Jun 1;85(11):946-955. PubMed PMID: 30679032; PubMed Central PMCID: PMC6534468.
  6. Bergen AW, Do EK, Chen LS, David SP. Tobacco Genomics: Complexity and Translational Challenges. Nicotine Tob Res. 2019 May 21;21(6):705-706. PubMed PMID: 31111930; PubMed Central PMCID: PMC6528148.
  7. Liu M, Jiang Y, Wedow R, Li Y, Brazel DM, Chen F, Datta G, Davila-Velderrain J, McGuire D, Tian C, Zhan X, Choquet H, Docherty AR, Faul JD, Foerster JR, Fritsche LG, Gabrielsen ME, Gordon SD, Haessler J, Hottenga JJ, Huang H, Jang SK, Jansen PR, Ling Y, Mägi R, Matoba N, McMahon G, Mulas A, Orrù V, Palviainen T, Pandit A, Reginsson GW, Skogholt AH, Smith JA, Taylor AE, Turman C, Willemsen G, Young H, Young KA, Zajac GJM, Zhao W, Zhou W, Bjornsdottir G, Boardman JD, Boehnke M, Boomsma DI, Chen C, Cucca F, Davies GE, Eaton CB, Ehringer MA, Esko T, Fiorillo E, Gillespie NA, Gudbjartsson DF, Haller T, Harris KM, Heath AC, Hewitt JK, Hickie IB, Hokanson JE, Hopfer CJ, Hunter DJ, Iacono WG, Johnson EO, Kamatani Y, Kardia SLR, Keller MC, Kellis M, Kooperberg C, Kraft P, Krauter KS, Laakso M, Lind PA, Loukola A, Lutz SM, Madden PAF, Martin NG, McGue M, McQueen MB, Medland SE, Metspalu A, Mohlke KL, Nielsen JB, Okada Y, Peters U, Polderman TJC, Posthuma D, Reiner AP, Rice JP, Rimm E, Rose RJ, Runarsdottir V, Stallings MC, Stančáková A, Stefansson H, Thai KK, Tindle HA, Tyrfingsson T, Wall TL, Weir DR, Weisner C, Whitfield JB, Winsvold BS, Yin J, Zuccolo L, Bierut LJ, Hveem K, Lee JJ, Munafò MR, Saccone NL, Willer CJ, Cornelis MC, David SP, Hinds DA, Jorgenson E, Kaprio J, Stitzel JA, Stefansson K, Thorgeirsson TE, Abecasis G, Liu DJ, Vrieze S. Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet. 2019 Feb;51(2):237-244. PubMed PMID: 30643251; PubMed Central PMCID: PMC6358542.
  8. Erzurumluoglu AM, Liu M, Jackson VE, Barnes DR, Datta G, Melbourne CA, Young R, Batini C, Surendran P, Jiang T, Adnan SD, Afaq S, Agrawal A, Altmaier E, Antoniou AC, Asselbergs FW, Baumbach C, Bierut L, Bertelsen S, Boehnke M, Bots ML, Brazel DM, Chambers JC, Chang-Claude J, Chen C, Corley J, Chou YL, David SP, de Boer RA, de Leeuw CA, Dennis JG, Dominiczak AF, Dunning AM, Easton DF, Eaton C, Elliott P, Evangelou E, Faul JD, Foroud T, Goate A, Gong J, Grabe HJ, Haessler J, Haiman C, Hallmans G, Hammerschlag AR, Harris SE, Hattersley A, Heath A, Hsu C, Iacono WG, Kanoni S, Kapoor M, Kaprio J, Kardia SL, Karpe F, Kontto J, Kooner JS, Kooperberg C, Kuulasmaa K, Laakso M, Lai D, Langenberg C, Le N, Lettre G, Loukola A, Luan J, Madden PAF, Mangino M, Marioni RE, Marouli E, Marten J, Martin NG, McGue M, Michailidou K, Mihailov E, Moayyeri A, Moitry M, Müller-Nurasyid M, Naheed A, Nauck M, Neville MJ, Nielsen SF, North K, Perola M, Pharoah PDP, Pistis G, Polderman TJ, Posthuma D, Poulter N, Qaiser B, Rasheed A, Reiner A, Renström F, Rice J, Rohde R, Rolandsson O, Samani NJ, Samuel M, Schlessinger D, Scholte SH, Scott RA, Sever P, Shao Y, Shrine N, Smith JA, Starr JM, Stirrups K, Stram D, Stringham HM, Tachmazidou I, Tardif JC, Thompson DJ, Tindle HA, Tragante V, Trompet S, Turcot V, Tyrrell J, Vaartjes I, van der Leij AR, van der Meer P, Varga TV, Verweij N, Völzke H, Wareham NJ, Warren HR, Weir DR, Weiss S, Wetherill L, Yaghootkar H, Yavas E, Jiang Y, Chen F, Zhan X, Zhang W, Zhao W, Zhao W, Zhou K, Amouyel P, Blankenberg S, Caulfield MJ, Chowdhury R, Cucca F, Deary IJ, Deloukas P, Di Angelantonio E, Ferrario M, Ferrières J, Franks PW, Frayling TM, Frossard P, Hall IP, Hayward C, Jansson JH, Jukema JW, Kee F, Männistö S, Metspalu A, Munroe PB, Nordestgaard BG, Palmer CNA, Salomaa V, Sattar N, Spector T, Strachan DP, van der Harst P, Zeggini E, Saleheen D, Butterworth AS, Wain LV, Abecasis GR, Danesh J, Tobin MD, Vrieze S, Liu DJ, Howson JMM. Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci. Mol Psychiatry. 2019 Jan 7;. [Epub ahead of print] PubMed PMID: 30617275.
  9. Natarajan P, Peloso GM, Zekavat SM, Montasser M, Ganna A, Chaffin M, Khera AV, Zhou W, Bloom JM, Engreitz JM, Ernst J, O'Connell JR, Ruotsalainen SE, Alver M, Manichaikul A, Johnson WC, Perry JA, Poterba T, Seed C, Surakka IL, Esko T, Ripatti S, Salomaa V, Correa A, Vasan RS, Kellis M, Neale BM, Lander ES, Abecasis G, Mitchell B, Rich SS, Wilson JG, Cupples LA, Rotter JI, Willer CJ, Kathiresan S. Deep-coverage whole genome sequences and blood lipids among 16,324 individuals. Nat Commun. 2018 Aug 23;9(1):3391. PubMed PMID: 30140000; PubMed Central PMCID: PMC6107638.
  10. Zekavat SM, Ruotsalainen S, Handsaker RE, Alver M, Bloom J, Poterba T, Seed C, Ernst J, Chaffin M, Engreitz J, Peloso GM, Manichaikul A, Yang C, Ryan KA, Fu M, Johnson WC, Tsai M, Budoff M, Vasan RS, Cupples LA, Rotter JI, Rich SS, Post W, Mitchell BD, Correa A, Metspalu A, Wilson JG, Salomaa V, Kellis M, Daly MJ, Neale BM, McCarroll S, Surakka I, Esko T, Ganna A, Ripatti S, Kathiresan S, Natarajan P. Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries. Nat Commun. 2018 Jul 4;9(1):2606. PubMed PMID: 29973585; PubMed Central PMCID: PMC6031652.
  11. Puryear L, Downs N, Nevedal A, Lewis ET, Ormond KE, Bregendahl M, Suarez CJ, David SP, Charlap S, Chu I, Asch SM, Pakdaman N, Chang SI, Cullen MR, Palaniappan L. Patient and provider perspectives on the development of personalized medicine: a mixed-methods approach. J Community Genet. 2018 Jul;9(3):283-291. PubMed PMID: 29280052; PubMed Central PMCID: PMC6002302.
  12. Salloum NC, Buchalter ELF, Chanani S, Espejo G, Ismail MS, Laine RO, Nageeb M, Srivastava AB, Trapp N, Trillo L, Vance E, Wenzinger M, Hartz SM, David SP, Chen LS. From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. Pharmacogenomics. 2018 Jul 1;19(10):861-871. PubMed PMID: 29914292; PubMed Central PMCID: PMC6219447.
  13. David SP, Palaniappan L. Clinical and Personal Utility of Genetic Risk Testing. Am Fam Physician. 2018 May 1;97(9):600-602. PubMed PMID: 29763257.
  14. David SP, Naudet F, Laude J, Radua J, Fusar-Poli P, Chu I, Stefanick ML, Ioannidis JPA. Potential Reporting Bias in Neuroimaging Studies of Sex Differences. Sci Rep. 2018 Apr 17;8(1):6082. PubMed PMID: 29666377; PubMed Central PMCID: PMC5904173.
  15. Saccone NL, Baurley JW, Bergen AW, David SP, Elliott HR, Foreman MG, Kaprio J, Piasecki TM, Relton CL, Zawertailo L, Bierut LJ, Tyndale RF, Chen LS. The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings. Nicotine Tob Res. 2018 Mar 6;20(4):403-413. PubMed PMID: 28472521; PubMed Central PMCID: PMC5896536.
  16. Chen LS, Zawertailo L, Piasecki TM, Kaprio J, Foreman M, Elliott HR, David SP, Bergen AW, Baurley JW, Tyndale RF, Baker TB, Bierut LJ, Saccone NL. Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How. Nicotine Tob Res. 2018 Mar 6;20(4):414-424. PubMed PMID: 28498934; PubMed Central PMCID: PMC5896450.
  17. Sarnowski C, Satizabal CL, DeCarli C, Pitsillides AN, Cupples LA, Vasan RS, Wilson JG, Bis JC, Fornage M, Beiser AS, DeStefano AL, Dupuis J, Seshadri S. Whole genome sequence analyses of brain imaging measures in the Framingham Study. Neurology. 2018 Jan 16;90(3):e188-e196. PubMed PMID: 29282330; PubMed Central PMCID: PMC5772158.
  18. Schuit E, Panagiotou OA, Munafò MR, Bennett DA, Bergen AW, David SP. Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. Cochrane Database Syst Rev. 2017 Sep 8;9:CD011823. PubMed PMID: 28884473; PubMed Central PMCID: PMC6483659.
  19. Laude JR, Bailey SR, Crew E, Varady A, Lembke A, McFall D, Jeon A, Killen D, Killen JD, David SP. Extended treatment for cigarette smoking cessation: a randomized control trial. Addiction. 2017 Aug;112(8):1451-1459. PubMed PMID: 28239942; PubMed Central PMCID: PMC5503769.
  20. David SP. Novel Methodologies and the Need for Big Data in Nicotine and Tobacco Genetics Research. Nicotine Tob Res. 2017 Apr 1;19(4):385-386. doi: 10.1093/ntr/ntx005. PubMed PMID: 28393169.
  21. An Evidence Framework for Genetic Testing. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Board on the Health of Select Populations; Committee on the Evidence Base for Genetic Testing. An Evidence Framework for Genetic Testing. Washington (DC): National Academies Press (US); 2017. PubMed PMID: 28418631.
  22. MacKillop J, Gray JC, Owens MM, Laude J, David S. Tobacco Use Disorder . In: Integrating Psychological and Pharmacological Treatments for Addictive Disorders. MacKillop J, Kenna GA, Leggio L, Ray LA, editors. New York, NY: Routledge; 2017. Chapter 5. 234p.
  23. Genomic and Precision Medicine, 3rd Edition, Primary Care. Third ed. David SP, editor. Kidlington, UK: Academic Press; 2017. 370p.
  24. Shields PG, Herbst RS, Arenberg D, Benowitz NL, Bierut L, Luckart JB, Cinciripini P, Collins B, David S, Davis J, Hitsman B, Hyland A, Lang M, Leischow S, Park ER, Purcell WT, Selzle J, Silber A, Spencer S, Tanvetyanon T, Tiep B, Tindle HA, Tucker-Seeley R, Urbanic J, Hooper MW, Weksler B, Whitlock CW, Wood DE, Burns J, Scavone J. Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 Nov;14(11):1430-1468. PubMed PMID: 27799513.
  25. Weng DY, Chen J, Taslim C, Hsu PC, Marian C, David SP, Loffredo CA, Shields PG. Persistent alterations of gene expression profiling of human peripheral blood mononuclear cells from smokers. Mol Carcinog. 2016 Oct;55(10):1424-37. Epub 2015 Aug 21. PubMed PMID: 26294040; PubMed Central PMCID: PMC4860148.
  26. Leyro TM, Crew EE, Bryson SW, Lembke A, Bailey SR, Prochaska JJ, Henriksen L, Fortmann SP, Killen JD, Killen DT, Hall SM, David SP. Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence. BMJ Open. 2016 Jun 29;6(6):e010960. PubMed PMID: 27357195; PubMed Central PMCID: PMC4932265.
  27. David SP, Wang A, Kapphahn K, Hedlin H, Desai M, Henderson M, Yang L, Walsh KM, Schwartz AG, Wiencke JK, Spitz MR, Wenzlaff AS, Wrensch MR, Eaton CB, Furberg H, Mark Brown W, Goldstein BA, Assimes T, Tang H, Kooperberg CL, Quesenberry CP, Tindle H, Patel MI, Amos CI, Bergen AW, Swan GE, Stefanick ML. Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans. EBioMedicine. 2016 Feb;4:153-61. PubMed PMID: 26981579; PubMed Central PMCID: PMC4776066.
  28. David SP, Amos CI. Gene by Environment Interaction Linking the Chromosome 15q25 Locus with Cigarette Consumption and Lung Cancer Susceptibility--Are African American Affected Differently?--Authors' Reply. EBioMedicine. 2016 Feb;4:15. PubMed PMID: 26981563; PubMed Central PMCID: PMC4776065.
  29. Ockene JK, Hayes RB, Churchill LC, Crawford SL, Jolicoeur DG, Murray DM, Shoben AB, David SP, Ferguson KJ, Huggett KN, Adams M, Okuliar CA, Gross RL, Bass PF 3rd, Greenberg RB, Leone FT, Okuyemi KS, Rudy DW, Waugh JB, Geller AC. Teaching Medical Students to Help Patients Quit Smoking: Outcomes of a 10-School Randomized Controlled Trial. J Gen Intern Med. 2016 Feb;31(2):172-181. PubMed PMID: 26391030; PubMed Central PMCID: PMC4720645.
  30. Strong DR, David SP, Johnstone EC, Aveyard P, Murphy MF, Munafò MR. Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers. Nicotine Tob Res. 2015 Jul;17(7):855-61. PubMed PMID: 25481918; PubMed Central PMCID: PMC4542679.
  31. David SP, Johnson SG, Berger AC, Feero WG, Terry SF, Green LA, Phillips RL Jr, Ginsburg GS. Making Personalized Health Care Even More Personalized: Insights From Activities of the IOM Genomics Roundtable. Ann Fam Med. 2015 Jul-Aug;13(4):373-80. PubMed PMID: 26195686; PubMed Central PMCID: PMC4508182.
  32. Hayes RB, Geller AC, Crawford SL, Jolicoeur DG, Churchill LC, Okuyemi KS, David SP, Adams M, Waugh J, Allen SS, Leone FT, Fauver R, Leung K, Liu Q, Ockene JK. Medical school curriculum characteristics associated with intentions and frequency of tobacco dependence treatment among 3rd year U.S. medical students. Prev Med. 2015 Mar;72:56-63. Epub 2015 Jan 5. PubMed PMID: 25572623; PubMed Central PMCID: PMC4562320.
  33. Henderson MT, Kubo JT, Desai M, David SP, Tindle H, Sinha AA, Seiffert-Sinha K, Hou L, Messina C, Saquib N, Stefanick ML, Tang JY. Smoking behavior and association of melanoma and nonmelanoma skin cancer in the Women's Health Initiative. J Am Acad Dermatol. 2015 Jan;72(1):190-1.e3. PubMed PMID: 25497923; PubMed Central PMCID: PMC4509504.
  34. Drug Repurposing and Repositioning: Workshop Summary. Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine. Drug Repurposing and Repositioning: Workshop Summary. Washington (DC): National Academies Press (US); 2014. PubMed PMID: 24872991.
  35. Zhu AZ, Zhou Q, Cox LS, David SP, Ahluwalia JS, Benowitz NL, Tyndale RF. Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers. Clin Pharmacol Ther. 2014 Aug;96(2):256-65. PubMed PMID: 24733007; PubMed Central PMCID: PMC4111775.
  36. Fusar-Poli P, Radua J, Frascarelli M, Mechelli A, Borgwardt S, Di Fabio F, Biondi M, Ioannidis JP, David SP. Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders. Hum Brain Mapp. 2014 Jul;35(7):3052-65. PMID: 24123491.
  37. Xu X, Clark US, David SP, Mulligan RC, Knopik VS, McGeary J, MacKillop J, McCaffery J, Niaura RS, Sweet LH. Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype. Nicotine Tob Res. 2014 Jul;16(7):939-47. PubMed PMID: 24659022; PubMed Central PMCID: PMC4072897.
  38. Ioannidis JP, Munafò MR, Fusar-Poli P, Nosek BA, David SP. Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention. Trends Cogn Sci. 2014 May;18(5):235-41. Epub 2014 Mar 18. Review. PubMed PMID: 24656991; PubMed Central PMCID: PMC4078993.
  39. Passarelli MN, Newcomb PA, Makar KW, Burnett-Hartman AN, Phipps AI, David SP, Hsu L, Harrison TA, Hutter CM, Duggan DJ, White E, Chan AT, Peters U. No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women. Menopause. 2014 Apr;21(4):415-20. PubMed PMID: 23880798; PubMed Central PMCID: PMC3865220.
  40. David SP, Chu IM, Lancaster T, Stead LF, Evins AE, Prochaska JJ. Systematic review and meta-analysis of opioid antagonists for smoking cessation. BMJ Open. 2014 Mar 14;4(3):e004393. PubMed PMID: 24633528; PubMed Central PMCID: PMC3963070.
  41. Dewey FE, Grove ME, Pan C, Goldstein BA, Bernstein JA, Chaib H, Merker JD, Goldfeder RL, Enns GM, David SP, Pakdaman N, Ormond KE, Caleshu C, Kingham K, Klein TE, Whirl-Carrillo M, Sakamoto K, Wheeler MT, Butte AJ, Ford JM, Boxer L, Ioannidis JP, Yeung AC, Altman RB, Assimes TL, Snyder M, Ashley EA, Quertermous T. Clinical interpretation and implications of whole-genome sequencing. JAMA. 2014 Mar 12;311(10):1035-45. PubMed PMID: 24618965; PubMed Central PMCID: PMC4119063.
  42. Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests: Workshop Summary. 2014 Mar 6;.
  43. Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine. Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests: Workshop Summary. Washington (DC): National Academies Press (US); 2014. PubMed PMID: 24555210.
  44. Hayes RB, Geller A, Churchill L, Jolicoeur D, Murray DM, Shoben A, David SP, Adams M, Okuyemi K, Fauver R, Gross R, Leone F, Xiao R, Waugh J, Crawford S, Ockene JK. Teaching tobacco dependence treatment and counseling skills during medical school: rationale and design of the Medical Students helping patients Quit tobacco (MSQuit) group randomized controlled trial. Contemp Clin Trials. 2014 Mar;37(2):284-93. doi: 10.1016/j.cct.2014.01.008. Epub 2014 Jan 31. PubMed PMID: 24486635; PubMed Central PMCID: PMC4048818.
  45. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine. Improving the Efficiency and Effectiveness of Genomic Science Translation: Workshop Summary. Washington (DC): National Academies Press (US); 2014. PubMed PMID: 24830073.
  46. David SP. Commentary on Chen et al. (2014): another step on the road to clinical utility of pharmacogenetics for smoking cessation?. Addiction. 2014 Jan;109(1):138-9. PubMed PMID: 24438115.
  47. David SP, Strong DR, Leventhal AM, Lancaster MA, McGeary JE, Munafò MR, Bergen AW, Swan GE, Benowitz NL, Tyndale RF, Conti DV, Brown RA, Lerman C, Niaura R. Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction. 2013 Dec;108(12):2202-11. PubMed PMID: 23941313; PubMed Central PMCID: PMC3834197.
  48. Geller AC, Hayes RB, Leone F, Churchill LC, Leung K, Reed G, Jolicoeur D, Okuliar C, Adams M, Murray DM, Liu Q, Waugh J, David S, Ockene JK. Tobacco dependence treatment teaching by medical school clerkship preceptors: survey responses from more than 1,000 US medical students. Prev Med. 2013 Aug;57(2):81-6. PubMed PMID: 23623894; PubMed Central PMCID: PMC3767283.
  49. David SP, Ware JJ, Chu IM, Loftus PD, Fusar-Poli P, Radua J, Munafò MR, Ioannidis JP. Potential reporting bias in fMRI studies of the brain. PLoS One. 2013;8(7):e70104. PMID: 23936149; PubMed Central PMCID: PMC3723634.
  50. David SP, Lancaster T, Stead LF, Evins AE, Prochaska JJ. Opioid antagonists for smoking cessation. Cochrane Database Syst Rev. 2013 Jun 6;(6):CD003086. PubMed PMID: 23744347; PubMed Central PMCID: PMC4038652.
  51. Bough KJ, Lerman C, Rose JE, McClernon FJ, Kenny PJ, Tyndale RF, David SP, Stein EA, Uhl GR, Conti DV, Green C, Amur S. Biomarkers for smoking cessation. Clin Pharmacol Ther. 2013 Jun;93(6):526-38. Epub 2013 Mar 18. Review. PubMed PMID: 23588313; PubMed Central PMCID: PMC3772534.
  52. Griswold KS, Lesko SE, Westfall JM. Communities of solution: partnerships for population health. J Am Board Fam Med. 2013 May-Jun;26(3):232-8. PubMed PMID: 23657688.
  53. McClure JB, Swan GE, St John J, Fauver R, Javitz HS, Bergen AW, Nishita D, Niaura R, Munafò MR, David SP. Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study. Nicotine Tob Res. 2013 Feb;15(2):518-26. PubMed PMID: 22949583; PubMed Central PMCID: PMC3611995.
  54. Mallick A, David SP. Pharmacogenomic Tailored Therapy for Smoking Cessation: The Promise of Personalized Medicine. In: Lifestyle Medicine. 2 ed. Rippe J, editor. Shrewsbury, MA: CRC Press; 2013. Chapter 102. 1638p.
  55. Liu T, Tyndale RF, David SP, Wang H, Yu XQ, Chen W, Wen XZ, Chen WQ. Association between daily cigarette consumption and hypertension moderated by CYP2A6 genotypes in Chinese male current smokers. J Hum Hypertens. 2013 Jan;27(1):24-30. PubMed PMID: 22217675; PubMed Central PMCID: PMC4128783.
  56. The Economics of Genomic Medicine: Workshop Summary. Institute of Medicine (US); Roundtable on Translating Genomic-Based Research for Health. The Economics of Genomic Medicine: Workshop Summary. Washington (DC): National Academies Press (US); 2013. PubMed PMID: 24199259.
  57. McDonagh EM, Wassenaar C, David SP, Tyndale RF, Altman RB, Whirl-Carrillo M, Klein TE. PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6. Pharmacogenet Genomics. 2012 Sep;22(9):695-708. PubMed PMID: 22547082; PubMed Central PMCID: PMC3413746.
  58. Improving America's health requires community-level solutions: Folsom revisited. Am Fam Physician. 2012 Aug 15;86(4):1-2. PubMed PMID: 23130357.
  59. Bergen AW, Mallick A, Nishita D, Wei X, Michel M, Wacholder A, David SP, Swan GE, Reid MW, Simons A, Andrews JA. Chronic psychosocial stressors and salivary biomarkers in emerging adults. Psychoneuroendocrinology. 2012 Aug;37(8):1158-70. PubMed PMID: 22172638; PubMed Central PMCID: PMC3774595.
  60. MacKillop J, Amlung MT, Wier LM, David SP, Ray LA, Bickel WK, Sweet LH. The neuroeconomics of nicotine dependence: a preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers. Psychiatry Res. 2012 Apr 30;202(1):20-9. PubMed PMID: 22633679; PubMed Central PMCID: PMC3530421.
  61. David SP, Hamidovic A, Chen GK, Bergen AW, Wessel J, Kasberger JL, Brown WM, Petruzella S, Thacker EL, Kim Y, Nalls MA, Tranah GJ, Sung YJ, Ambrosone CB, Arnett D, Bandera EV, Becker DM, Becker L, Berndt SI, Bernstein L, Blot WJ, Broeckel U, Buxbaum SG, Caporaso N, Casey G, Chanock SJ, Deming SL, Diver WR, Eaton CB, Evans DS, Evans MK, Fornage M, Franceschini N, Harris TB, Henderson BE, Hernandez DG, Hitsman B, Hu JJ, Hunt SC, Ingles SA, John EM, Kittles R, Kolb S, Kolonel LN, Le Marchand L, Liu Y, Lohman KK, McKnight B, Millikan RC, Murphy A, Neslund-Dudas C, Nyante S, Press M, Psaty BM, Rao DC, Redline S, Rodriguez-Gil JL, Rybicki BA, Signorello LB, Singleton AB, Smoller J, Snively B, Spring B, Stanford JL, Strom SS, Swan GE, Taylor KD, Thun MJ, Wilson AF, Witte JS, Yamamura Y, Yanek LR, Yu K, Zheng W, Ziegler RG, Zonderman AB, Jorgenson E, Haiman CA, Furberg H. Genome-wide meta-analyses of smoking behaviors in African Americans. Transl Psychiatry. 2012 May 22;2:e119. PubMed PMID: 22832964; PubMed Central PMCID: PMC3365260.
  62. Chen LS, Saccone NL, Culverhouse RC, Bracci PM, Chen CH, Dueker N, Han Y, Huang H, Jin G, Kohno T, Ma JZ, Przybeck TR, Sanders AR, Smith JA, Sung YJ, Wenzlaff AS, Wu C, Yoon D, Chen YT, Cheng YC, Cho YS, David SP, Duan J, Eaton CB, Furberg H, Goate AM, Gu D, Hansen HM, Hartz S, Hu Z, Kim YJ, Kittner SJ, Levinson DF, Mosley TH, Payne TJ, Rao DC, Rice JP, Rice TK, Schwantes-An TH, Shete SS, Shi J, Spitz MR, Sun YV, Tsai FJ, Wang JC, Wrensch MR, Xian H, Gejman PV, He J, Hunt SC, Kardia SL, Li MD, Lin D, Mitchell BD, Park T, Schwartz AG, Shen H, Wiencke JK, Wu JY, Yokota J, Amos CI, Bierut LJ. Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. Genet Epidemiol. 2012 May;36(4):340-51. PubMed PMID: 22539395; PubMed Central PMCID: PMC3387741.
  63. Communities of solution: the Folsom Report revisited. Ann Fam Med. 2012 May-Jun;10(3):250-60. PubMed PMID: 22585890; PubMed Central PMCID: PMC3354975.
  64. Liu T, David SP, Tyndale RF, Wang H, Yu XQ, Chen W, Zhou Q, Chen WQ. Relationship between amounts of daily cigarette consumption and abdominal obesity moderated by CYP2A6 genotypes in Chinese male current smokers. Ann Behav Med. 2012 Apr;43(2):253-61. PubMed PMID: 22160797; PubMed Central PMCID: PMC4114962.
  65. Leventhal AM, David SP, Brightman M, Strong D, McGeary JE, Brown RA, Lloyd-Richardson EE, Munafò M, Uhl GR, Niaura R. Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. Pharmacogenomics J. 2012 Feb;12(1):86-92. PubMed PMID: 20661272; PubMed Central PMCID: PMC2981689.
  66. David SP, McClure JM, Swan GE. Nicotine Dependence. In: Handbook of Psychology. Weiner IB, Nezue AM, Geller PA, editors. Hoboken, NJ: John Wiley & Sons, Inc; 2012. Chapter 7. 704p. Genome-Based Therapeutics: Targeted Drug Discovery and Development: Workshop Summary. 2012;. doi: 10.17226/13436. Review. PubMed PMID: 23346605.
  67. Janes AC, Smoller JW, David SP, Frederick BD, Haddad S, Basu A, Fava M, Evins AE, Kaufman MJ. Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women. Drug Alcohol Depend. 2012 Jan 1;120(1-3):7-13. PubMed PMID: 21764527; PubMed Central PMCID: PMC3203995.
  68. Liu T, Chen WQ, David SP, Tyndale RF, Wang H, Chen YM, Yu XQ, Chen W, Zhou Q, Ling WH. Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways. Eur J Endocrinol. 2011 Dec;165(6):961-7. PubMed PMID: 21964962; PubMed Central PMCID: PMC4112659.
  69. Dewey FE, Chen R, Cordero SP, Ormond KE, Caleshu C, Karczewski KJ, Whirl-Carrillo M, Wheeler MT, Dudley JT, Byrnes JK, Cornejo OE, Knowles JW, Woon M, Sangkuhl K, Gong L, Thorn CF, Hebert JM, Capriotti E, David SP, Pavlovic A, West A, Thakuria JV, Ball MP, Zaranek AW, Rehm HL, Church GM, West JS, Bustamante CD, Snyder M, Altman RB, Klein TE, Butte AJ, Ashley EA. Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet. 2011 Sep;7(9):e1002280. PubMed PMID: 21935354; PubMed Central PMCID: PMC3174201.
  70. Liu T, David SP, Tyndale RF, Wang H, Zhou Q, Ding P, He YH, Yu XQ, Chen W, Crump C, Wen XZ, Chen WQ. Associations of CYP2A6 genotype with smoking behaviors in southern China. Addiction. 2011 May;106(5):985-94. PubMed PMID: 21205058; PubMed Central PMCID: PMC3074015.
  71. David SP, Johnstone EC, Churchman M, Aveyard P, Murphy MF, Munafò MR. Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials. Nicotine Tob Res. 2011 Mar;13(3):157-67. PubMed Central PMCID: PMC3107615.
  72. David SP, Sweet LH, Cohen RA, MacKillop J, Mulligan RC, Niaura R. Application of Functional Neuroimaging Methods to Examination of Nicotine Dependence. In: Brain Imaging in Behavioral Medicine and Clinical Neuroscience. 1 ed. Cohen RA, Sweet LH, editors. New York, NY: Springer; 2011. Chapter 9. 404p.
  73. Sweet LH, Mulligan RC, Finnerty CE, Jerskey BA, David SP, Cohen RA, Niaura RS. Effects of nicotine withdrawal on verbal working memory and associated brain response. Psychiatry Res. 2010 Jul 30;183(1):69-74. PubMed PMID: 20570495; PubMed Central PMCID: PMC2913712.
  74. David SP, Mezuk B, Zandi PP, Strong D, Anthony JC, Niaura R, Uhl GR, Eaton WW. Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans. Nicotine Tob Res. 2010 Mar;12(3):251-62. PubMed PMID: 20133381; PubMed Central PMCID: PMC2825103.
  75. Uhl GR, Drgon T, Johnson C, Walther D, David SP, Aveyard P, Murphy M, Johnstone EC, Munafò MR. Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. Pharmacogenomics. 2010 Mar;11(3):357-67. PubMed PMID: 20235792; PubMed Central PMCID: PMC3040594.
  76. Munafò MR, Timpson NJ, David SP, Ebrahim S, Lawlor DA. Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data. Nicotine Tob Res. 2009 Jan;11(1):64-76. PubMed PMID: 19246443; PubMed Central PMCID: PMC3203402.
  77. Koplan KE, David SP, Rigotti NA. [Smoking cessation]. Praxis (Bern 1994). 2008 Nov 5;97(22):1185-6. PubMed PMID: 18979437.
  78. David SP, Johnstone EC, Murphy MF, Aveyard P, Guo B, Lerman C, Munafò MR. Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. Drug Alcohol Depend. 2008 Nov 1;98(1-2):77-85. PubMed PMID: 18562131; PubMed Central PMCID: PMC4439462.
  79. David SP, Munafò MR. Genetic variation in the dopamine pathway and smoking cessation. Pharmacogenomics. 2008 Sep;9(9):1307-21. PubMed PMID: 18781857.
  80. Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE, David SP, Niaura R, Lerman C. Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry. 2008 Jun;65(6):683-93. PubMed PMID: 18519826; PubMed Central PMCID: PMC2430596.
  81. David SP, Munafò MR. Smoking cessation in primary care. BMJ. 2008 May 31;336(7655):1200-1. PubMed PMID: 18441374; PubMed Central PMCID: PMC2405833.
  82. David SP, Munafò MR, Murphy MF, Proctor M, Walton RT, Johnstone EC. Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. Pharmacogenomics J. 2008 Apr;8(2):122-8. PMID: 17387332; PubMed Central PMCID: PMC2288552.
  83. Koplan KE, David SP, Rigotti NA. Smoking cessation. BMJ. 2008 Jan 26;336(7637):217. PubMed PMID: 18219045; PubMed Central PMCID: PMC2213872.
  84. Welton NJ, Johnstone EC, David SP, Munafò MR. A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation. Nicotine Tob Res. 2008 Jan;10(1):231-40. PubMed PMID: 18188764; PubMed Central PMCID: PMC2257987.
  85. Paul RH, Grieve SM, Niaura R, David SP, Laidlaw DH, Cohen R, Sweet L, Taylor G, Clark RC, Pogun S, Gordon E. Chronic cigarette smoking and the microstructural integrity of white matter in healthy adults: a diffusion tensor imaging study. Nicotine Tob Res. 2008 Jan;10(1):137-47. PubMed PMID: 18188754; PubMed Central PMCID: PMC2276564.
  86. David SP, Strong DR, Munafò MR, Brown RA, Lloyd-Richardson EE, Wileyto PE, Evins AE, Shields PG, Lerman C, Niaura R. Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine Tob Res. 2007 Dec;9(12):1251-7. PubMed PMID: 18058343; PubMed Central PMCID: PMC2128730.
  87. David SP, Munafò MR, Johansen-Berg H, Mackillop J, Sweet LH, Cohen RA, Niaura R, Rogers RD, Matthews PM, Walton RT. Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study. Brain Imaging Behav. 2007 Dec;1(3-4):43-57. PubMed PMID: 18458752; PubMed Central PMCID: PMC2367252.
  88. David SP, Smith M, Lee CS, Sullivan G. Successful Latino community partnership program for smoking cessation. Am J Public Health. 2007 Aug;97(8):1348-9; author reply 1349. PubMed PMID: 17600240; PubMed Central PMCID: PMC1931457.
  89. David SP, Brown RA, Papandonatos GD, Kahler CW, Lloyd-Richardson EE, Munafò MR, Shields PG, Lerman C, Strong D, McCaffery J, Niaura R. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob Res. 2007 Aug;9(8):821-33. PubMed PMID: 17654295; PubMed Central PMCID: PMC2039873.
  90. Johnstone EC, Elliot KM, David SP, Murphy MF, Walton RT, Munafò MR. Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1065-9. PubMed PMID: 17548664; PubMed Central PMCID: PMC2031911.
  91. David SP, Munafò MR, Murphy MF, Walton RT, Johnstone EC. The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial. Nicotine Tob Res. 2007 Feb;9(2):225-31. PubMed PMID: 17365753; PubMed Central PMCID: PMC2031912.
  92. David SP, Eaton CB, Culpepper L, Goldman RE, Lavallee LK, Simmons EM. Building a successful research enterprise in family medicine: the Brown experience. Med Health R I. 2006 Aug;89(8):281-4. PubMed PMID: 16967659; PubMed Central PMCID: PMC1992529.
  93. Long R, David SP, Monroe A, Shaw J. Fellowship training in family medicine at Brown: adding depth to breadth. Med Health R I. 2006 Aug;89(8):274-5. PubMed PMID: 16967657.
  94. David SP, Munafò MR, Walton RT. The Pharmacogenomics of Nicotine Addiction and Smoking Cessation. In: Pharmacogenomics and Proteomics. 1 ed. Wong SH, editor. Washington, DC: AACC Press; 2006. Chapter 21. 386p.
  95. David SP, Munafò MR, Johansen-Berg H, Smith SM, Rogers RD, Matthews PM, Walton RT. Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry. 2005 Sep 15;58(6):488-94. PubMed PMID: 16023086; PubMed Central PMCID: PMC4439461.
  96. David SP, Murthy NV, Rabiner EA, Munafó MR, Johnstone EC, Jacob R, Walton RT, Grasby PM. A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci. 2005 Mar 9;25(10):2586-90. PubMed PMID: 15758168; PubMed Central PMCID: PMC1942077.
  97. David SP. Studies of genetic influences on nicotine dependence utilising functional neuroimaging (PhD thesis). University of Oxford. Oxford, UK: University of Oxford; 2005. 269p.
  98. David SP, Eaton CB, Taylor JS, Stamp MJ, Cyr M, Siegel B, Gramling R, Walton R. Envisaging and applying a unifying three-dimensional theoretical framework for generalist physicians. Med Health R I. 2004 Nov;87(11):336-40. PubMed PMID: 15631301.
  99. Gramling R, Duffy C, David S. Does providing hereditary breast cancer risk assessment support to practicing physicians decrease the likelihood of them discussing such risk with their patients?. Genet Med. 2004 Nov-Dec;6(6):542. PubMed PMID: 15545753.
  100. David SP, Taylor JS, Monroe A, Goldman R, Green AR, Boss J, Sagaties D. Evaluation of an Educational Intervention for Medical Students to Promote Competency in Social and Community Determinants of Health. Annals of behavioral science and medical education : journal of the Association for the Behavioral Sciences and Medical Education. Fall 2004; 10(2):68-73.
  101. Munafò M, Bradburn M, Bowes L, David S. Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. Nicotine Tob Res. 2004 Oct;6(5):769-76. PubMed PMID: 15700912.
  102. David SP. Pharmacogenetics. Prim Care. 2004 Sep;31(3):543-59, ix. PubMed PMID: 15331247.
  103. David SP, Niaura R, Papandonatos GD, Shadel WG, Burkholder GJ, Britt DM, Day A, Stumpff J, Hutchison K, Murphy M, Johnstone E, Griffiths SE, Walton RT. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?. Nicotine Tob Res. 2003 Dec;5(6):935-42. PubMed PMID: 14668077.
  104. David SP. Should we offer routine breast cancer screening with mammography?. Am Fam Physician. 2003 Jul 15;68(2):260-2. PubMed PMID: 12892345.
  105. Gramling R, David S. Genetic susceptibility to breast cancer: teaching points. Fam Med. 2003 Jul-Aug;35(7):466-8. PubMed PMID: 12861454.
  106. David SP, Eaton CB. Comment on "The public health implications of smoking-induced decreased serum and red blood cell folate levels". Nicotine Tob Res. 2003 Jun;5(3):397-9. doi: 10.1080/1462220031000094123. PubMed PMID: 12791535.
  107. Stamp MJ, David SP. Are family physicians willing to use pharmacogenetics for smoking cessation therapy?. Fam Med. 2003 Feb;35(2):83. PubMed PMID: 12607800.
  108. David SP. Should we prescribe antibiotics for acute conjunctivitis?. Am Fam Physician. 2002 Nov 1;66(9):1649-50. PubMed PMID: 12449262.
  109. David SP. Should we use multiple risk factor interventions for the primary prevention of coronary heart disease?. Am Fam Physician. 2002 Jul 15;66(2):245-6. PubMed PMID: 12152959.
  110. David SP, Johnstone E, Griffiths SE, Murphy M, Yudkin P, Mant D, Walton R. No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. Pharmacogenetics. 2002 Apr;12(3):265-8. doi: 10.1097/00008571-200204000-00011. PubMed PMID: 11927842.
  111. David SP. Should we recommend nicotine replacement therapy?. Am Fam Physician. 2001 Jun 1;63(11):2245-7. PubMed PMID: 11417777.
  112. David SP. A civic role for physicians in the promotion of global tobacco control. Fam Pract. 2001 Feb;18(1):107. PubMed PMID: 11145639.
  113. David SP, Greer DS. Social marketing: application to medical education. Ann Intern Med. 2001 Jan 16;134(2):125-7. PubMed PMID: 11177316.
  114. David SP. Media advocacy for the office-based teacher of family medicine. Fam Med. 2001 Jan;33(1):16-8. PubMed PMID: 11199903.
  115. David S, DeJong W, Resnick N. International tobacco control: a focus group study of U.S. anti-tobacco activists. J Public Health Policy. 2001;22(4):415-28. PubMed PMID: 11787307.
  116. David SP. Smoking cessation for the primary care physician. Primary Care Reports. 2001; 7(24):211-221.
  117. David SP. Reflections from a rotation in Cambridge, England. Fam Med. 2000 May;32(5):310-2. PubMed PMID: 10820671.
  118. David SP. The Transatlantic Conference on Tobacco (TACT): a model for international tobacco policy activism. J Cancer Educ. 1998 Winter;13(4):253-4. doi: 10.1080/08858199809528555. PubMed PMID: 9883786.

Publications

View more results at PubMed.gov